Who is sponsoring NCT03053700?

NCT03053700 is sponsored by Rabin Medical Center.

What drugs are being tested in NCT03053700?

Interventions: Bromonide 0.33% gel, Intense Pulsed Light (M22).

What is the status of NCT03053700?

NCT03053700 is currently WITHDRAWN.

Last reviewed 2022-10-31 · How we verify

Intense Pulsed Light as an Adjunctive to Bromonidine for the Treatment of Rosacea

NCT03053700 PHASE4 WITHDRAWN

This is an interventional and prospective study. The study is designed to evaluate the additional benefits of a combination of IPL treatment and local application of Bromonide 0.33% gel in the treatment of erythematotelangiectatic (ETR) and papulopustular (PPR).

Details

Lead sponsor	Rabin Medical Center
Phase	PHASE4
Status	WITHDRAWN
Start date	Sat Dec 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Jan 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Rosacea

Interventions

Bromonide 0.33% gel
Intense Pulsed Light (M22)

Countries

Israel